西印度群岛青光眼激光研究(WIGLS):1. 选择性激光小梁成形术在非裔加勒比青光眼患者中的12个月疗效
该阶梯楔形试验在圣卢西亚和多米尼克纳入72例已确诊原发性开角型青光眼的非裔加勒比患者,随机分为即刻洗脱后行选择性激光小梁成形术(SLT)、延迟3个月洗脱后SLT或延迟6个月洗脱后SLT,双眼360度SLT单次完成。洗脱后平均眼压从15.4 mm Hg升至约21.0 mm Hg,SLT后3至12个月平均眼压为12.5至14.5 mm Hg(降低29.7%至39.5%,P < .0001),12个月成功率为78%。结论认为SLT单药治疗可安全显著降低眼压。
要点
- 洗脱后平均眼压右眼21.0±3.3 mm Hg、左眼20.9±3.0 mm Hg,SLT后3至12个月降至12.5至14.5 mm Hg。
- 12个月成功率为78%,成功定义为双眼眼压≤目标眼压(较洗脱后基线降低20%或以上)。
- 暂时性畏光和不适常见。
核心结论
- SLT单药治疗可安全显著降低非裔加勒比原发性开角型青光眼患者的眼压。
- 该治疗可在资源有限地区对非洲裔人群预防青光眼视力丧失和盲发挥重要作用。
研究设计与样本
- 阶梯楔形试验,在圣卢西亚和多米尼克纳入已确诊原发性开角型青光眼的受试者。
- 受试者随机分为即刻洗脱后SLT、延迟3个月洗脱后SLT或延迟6个月洗脱后SLT。
- 洗脱后2个不同日测量基线眼压,单次完成双眼360度SLT。
- 治疗后1小时、1周及3、6、9、12个月评估。
- 共72例患者接受SLT治疗。
主要发现
- 入组时平均眼压右眼15.4±3.6 mm Hg、左眼15.4±3.6 mm Hg,洗脱后分别升至21.0±3.3 mm Hg和20.9±3.0 mm Hg。
- SLT后3、6、9、12个月平均眼压为12.5 mm Hg至14.5 mm Hg(降低29.7%至39.5%,每眼各时间点P < .0001)。
- 12个月成功率为78%。
- 暂时性畏光和不适常见。
关键数值与推荐
- 主要结局为12个月时SLT成功,定义为双眼眼压≤目标眼压。
- 目标眼压为较洗脱后基线眼压降低20%或以上。
临床怎么用
- SLT单药治疗可安全显著降低非裔加勒比原发性开角型青光眼患者的眼压。
- 该治疗可在资源有限地区对非洲裔人群预防青光眼视力丧失和盲发挥重要作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the 12-month intraocular pressure (IOP)-lowering efficacy of selective laser trabeculoplasty (SLT) as sole therapy for primary open-angle glaucoma (POAG) in an Afro-Caribbean population. DESIGN: Stepped-wedge trial. METHODS: Subjects in St. Lucia and Dominica with established POAG were randomized to prompt washout of IOP-lowering medications followed by SLT, 3-month delay followed by washout and SLT, or 6-month delay followed by washout and SLT. Baseline IOP was obtained on 2 different days after washout. Bilateral 360-degree SLT was performed in 1 session. Posttreatment assessments took place 1 hour, 1 week, and 3, 6, 9, and 12 months post-SLT. The main outcome measure was SLT success (defined as IOP ≤ target IOP in both eyes) at 12 months. Target IOP was a 20% or greater reduction in IOP from postwashout baseline. RESULTS: Overall, 72 patients underwent SLT treatment. Mean IOP at enrollment was 15.4 ± 3.6 mm Hg in right eyes and 15.4 ± 3.6 mm Hg in left eyes, which rose to 21.0 ± 3.3 mm Hg and 20.9 ± 3.0 mm Hg, respectively, after washout. Mean IOP at 3, 6, 9, and 12 months ranged from 12.5 mm Hg to 14.5 mm Hg (29.7% to 39.5%; P < .0001 in each eye at each time point). The 12-month success rate was 78%. Transient photophobia and discomfort were common. CONCLUSIONS: SLT monotherapy safely provides significant IOP reduction in Afro-Caribbean eyes with POAG. This treatment can play a significant role in preventing glaucoma vision loss and blindness in people of African descent living in resource-limited regions.
引用
- Realini T, Shillingford-Ricketts H, Burt D, et al. West Indies Glaucoma Laser Study (WIGLS): 1. 12-Month Efficacy of Selective Laser Trabeculoplasty in Afro-Caribbeans With Glaucoma. Am J Ophthalmol. 2017. PMID: 28962966. doi:10.1016/j.ajo.2017.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。